Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon

被引:30
作者
Oikawa, Yuji [1 ]
Yajima, Junji
Costa, Marco A. [2 ]
Matsuno, Shunsuke
Akabane, Masafumi
Funada, Ryuichi
Inaba, Toshiro
Nakagawa, Yuya
Nakamura, Michinari
Nagashima, Kazuyuki
Kirigaya, Hajime
Ogasawara, Ken
Sawada, Hitoshi
Aizawa, Tadanori
机构
[1] Cardiovasc Inst, Dept Cardiol, Minato Ku, Tokyo 1060032, Japan
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
Sirolimus-eluting stent; bare metal stent; atherectomy; NEOINTIMAL COVERAGE; CORONARY-ARTERY; DE-NOVO; THROMBOSIS; PATHOLOGY; HUMANS;
D O I
10.4244/EIJV6I3A63
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Histopathology of DES restenosis remains unclear. The purpose is to examine restenotic tissue characteristics after sirolimus-eluting stent (SES) and comparing with that after bare-metal stent (BMS). Methods and results: Intravascular ultrasound (IVUS), coronary angioscopy (CAS), and directional coronary atherectomy were performed simultaneously in 21 patients who presented restenosis after SES (n=13) and BMS (n=8). Mean time of restenosis was 10.8 months in the SES versus 7.5 months in the BMS. Typical "black hole", echolucent appearance by IVUS was observed in one SES case, and corresponded to a fibrin rich tissue by histology which appeared translucent tissue by CAS. CAS did not reveal red thrombus, but showed white thrombus in six SES versus two BMS (46.2% vs. 25.0%, p=0.597). Histology demonstrated various patterns after SES including thrombus, fibrin, inflammatory infiltrate, and collagen-matrix rich tissue, while thrombus component was not detected in BMS. Thrombus and fibrin deposition detected by either CAS or histopathology were observed more frequently in SES than in BMS group (92.3% vs. 25.0%, p=0.007). Conclusions: Restenosis after SES and BMS have different clinical and histological patterns. SES restenosis may be frequently associated with thrombus component.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 24 条
[1]   Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation [J].
Awata, Masaki ;
Kotani, Jun-ichi ;
Uematsu, Masaaki ;
Morozumi, Takakazu ;
Watanabe, Tetsuya ;
Onishi, Toshinari ;
Iida, Osamu ;
Sera, Fusako ;
Nanto, Shinsuke ;
Hori, Masatsugu ;
Nagata, Seiki .
CIRCULATION, 2007, 116 (08) :910-916
[2]  
Costa Jose de Ribamar Jr, 2006, J Invasive Cardiol, V18, P348
[3]   Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation [J].
Costa, MA ;
Sabate, M ;
Angiolillo, DJ ;
Jimenez-Quevedo, P ;
Teirstein, P ;
Carter, A ;
Leon, MB ;
Moses, J ;
Zenni, M ;
Yakubov, S ;
Guzman, LA ;
Gilmore, P ;
Macaya, C ;
Bass, TA .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02) :203-206
[4]   Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions [J].
Degertekin, M ;
Lemos, PA ;
Lee, CH ;
Tanabe, K ;
Sousa, JE ;
Abizaid, A ;
Regar, E ;
Sianos, G ;
van der Giessen, WJ ;
de Feyter, PJ ;
Wuelfert, E ;
Popma, JJ ;
Serruys, PW .
EUROPEAN HEART JOURNAL, 2004, 25 (01) :32-38
[5]   Pathology of acute and chronic coronary stenting in humans [J].
Farb, A ;
Sangiorgi, G ;
Carter, AJ ;
Walley, VM ;
Edwards, WD ;
Schwartz, RS ;
Virmani, R .
CIRCULATION, 1999, 99 (01) :44-52
[6]   Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis [J].
Fujii, K ;
Mintz, GS ;
Kobayashi, Y ;
Carlier, SG ;
Takebayashi, H ;
Yasuda, T ;
Moussa, I ;
Dangas, G ;
Mehran, R ;
Lansky, AJ ;
Reyes, A ;
Kreps, E ;
Collins, M ;
Colombo, A ;
Stone, GW ;
Teirstein, PS ;
Leon, MB ;
Moses, JW .
CIRCULATION, 2004, 109 (09) :1085-1088
[7]   Sirolimus-eluting stent implanted in human coronary artery for 16 months - Pathological findings [J].
Guagliumi, G ;
Farb, A ;
Musumeci, G ;
Valsecchi, O ;
Tespili, M ;
Motta, T ;
Virmani, R .
CIRCULATION, 2003, 107 (09) :1340-1341
[8]   Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents [J].
Iakovou, I ;
Schmidt, T ;
Bonizzoni, E ;
Ge, L ;
Sangiorgi, GM ;
Stankovic, G ;
Airoldi, F ;
Chieffo, A ;
Montorfano, M ;
Carlino, M ;
Michev, I ;
Corvaja, N ;
Briguori, C ;
Gerckens, U ;
Grube, E ;
Colombo, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2126-2130
[9]   Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].
Joner, Michael ;
Finn, Aloke V. ;
Farb, Andrew ;
Mont, Erik K. ;
Kolodgie, Frank D. ;
Ladich, Elena ;
Kutys, Robert ;
Skorija, Kristi ;
Gold, Herman K. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202
[10]  
Kay I Patrick, 2003, Int J Cardiovasc Intervent, V5, P137, DOI 10.1080/14628840304619